Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Hematopoietic Cell Transplantation: early-phase trial registry

3 of 5 indexed Hematopoietic Cell Transplantation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Hematopoietic Cell Transplantation: 5 US clinical trials tracked, 3 recruiting.

Hematopoietic Cell Transplantation is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is St. Jude Children's Research Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition hematopoietic-cell-transplantation

OPEN 3 | RECR 60% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Hematopoietic Cell Trans (th…60%
Open-enrollment share among volume-matched conditions near Hematopoietic Cell Transplantation

Hematopoietic Cell Transplantation lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hematopoietic Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hematopoietic Cell Transplantation is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hematopoietic Cell Transplantation research.

    St. Jude Children's Research Hospital accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Hematopoietic Cell Transplantation trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Hematopoietic Cell Transplantation research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Named interventions

Most-linked intervention names on Hematopoietic Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fecal Microbiota Transplant Biological
1 trials
Laronidase therapy and a stem cell transplant Drug
1 trials
Anti-Thymocyte Globulin (Rabbit) Drug
1 trials
Biorepository Trial Other
1 trials
Thiotepa Drug
1 trials
Mesna Drug
1 trials
Fludarabine Drug
1 trials
Cyclophosphamide Drug
1 trials

US sites by state

Facility locations filed on Hematopoietic Cell Transplantation trials. A trial with sites in several states counts in each.

Texas 2 trials
Minnesota 2 trials
Massachusetts 2 trials
Washington 1 trials
Tennessee 1 trials
North Carolina 1 trials
Michigan 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hematopoietic Cell Transplantation page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic Cell Transplantation condition card totals 5 registered trials; most-linked intervention Fecal Microbiota Transplant; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.